Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
OraSure Technologies Inc | OSUR | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
5.53 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 4.375 - 8.45 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 5.53 | USD |
OraSure Technologies Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
408.09M | 73.80M | - | 405.57M | 53.66M | 0.73 | 7.61 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
OraSure Technologies News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OSUR Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 5.23 | 5.53 | 5.185 | 5.32 | 757,975 | 0.30 | 5.74% |
1 Month | 6.11 | 6.35 | 5.185 | 5.76 | 745,290 | -0.58 | -9.49% |
3 Months | 7.52 | 8.04 | 5.185 | 6.63 | 933,452 | -1.99 | -26.46% |
6 Months | 5.31 | 8.45 | 5.035 | 6.98 | 813,641 | 0.22 | 4.14% |
1 Year | 7.15 | 8.45 | 4.375 | 6.43 | 715,073 | -1.62 | -22.66% |
3 Years | 9.49 | 13.57 | 2.62 | 6.76 | 779,031 | -3.96 | -41.73% |
5 Years | 9.48 | 20.00 | 2.62 | 9.16 | 913,311 | -3.95 | -41.67% |
OraSure Technologies Description
OraSure Technologies is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets most of its sales from the molecular solutions business, derived mainly from customers in the United States. |